Yarrow Bioscience, Inc.
corporate_fare Company Profile
Yarrow Bioscience, Inc. (NASDAQ:YARW) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 9 items for YARW at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-14, rated 7/10. Across its 9 most recent items scored 7 or higher, the top rating is 8/10, with 2 rated 8 or above. Recent SEC coverage for YARW spans 8-K, 424B5, 8-K/A, SCHEDULE 13D.
Recent high-impact activity:
- Yarrow Bioscience Closes $172.5M Offering After Full Underwriter Option Exercise
- Yarrow Upsizes Offering to $161.8M as Underwriters Exercise Full Overallotment
- Yarrow Bioscience Prices $150M Underwritten Offering at $26.00 Per Share
- Preliminary Prospectus for Underwritten Offering Reveals $108.8M Cash Position and Runway into 2030
- Yarrow Prices $150M Offering at $26, a 4.6% Discount to Last Close
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 126,528 shares in YARW as of the September 15, 2026 settlement, a 124.0% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 58.1% of YARW volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for YARW, detected from its recent SEC filings · based on capital-structure filings through 2026-09-11.
Underwritten Offering Priced at $26.00 · Net Proceeds of $140.7 Million
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →